A research paper, entitled “Nanofiber-based platform for quantitative analysis of human oligodendrocyte ensheathment with pharmacological perturbations,” was published in Stem Cell Reports.

The research team includes Haruhisa Inoue, Senior Visiting Scientist of the Medical-risk Avoidance based on iPS Cells Team at RIKEN AIP.

For more information, please see the following website.
CiRA Website

Related Laboratories